| Identifier |
20110208_nanos_posters_002 |
| Title |
Alemtuzumab Improves Contrast Sensitivity in Relapsing-Remitting Multiple Sclerosis Patients |
| Creator |
Laura Balcer; Steven Galetta; Maureen Maguire; Jeffrey Palmer; David Margolin; Marco Rizzo |
| Affiliation |
(SG) (MM) University of Pennsylvania, Philadelphia, PA; (JP) (DM) (MR) Genzyme Corporation, Cambridge, MA |
| Subject |
Contrast Sensitivity; Pelli-Robson, Multiple Sclerosis (MS); Vision; Alemtuzumab |
| Description |
Alemtuzumab is a humanized monoclonal antibody that alters the circulating lymphocyte pool. In a 3-year, phase 2 trial, alemtuzumab was superior to subcutaneous IFNB-1a in patients with early, active relapsing-remitting MS (RRMS), significantly reducing relapse rate, risk for sustained accumulation of disability, and mean disability. |
| Date |
2011-02-08 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
2011 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS 2011: Poster Presentations |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2011. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s66t3t4h |
| Setname |
ehsl_novel_nam |
| ID |
181645 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s66t3t4h |
